157 related articles for article (PubMed ID: 22173757)
1. Differentiation of tumefactive demyelinating lesions from high-grade gliomas with the use of diffusion tensor imaging.
Toh CH; Wei KC; Ng SH; Wan YL; Castillo M; Lin CP
AJNR Am J Neuroradiol; 2012 May; 33(5):846-51. PubMed ID: 22173757
[TBL] [Abstract][Full Text] [Related]
2. Performance of Apparent Diffusion Coefficient Values and Conventional MRI Features in Differentiating Tumefactive Demyelinating Lesions From Primary Brain Neoplasms.
Mabray MC; Cohen BA; Villanueva-Meyer JE; Valles FE; Barajas RF; Rubenstein JL; Cha S
AJR Am J Roentgenol; 2015 Nov; 205(5):1075-85. PubMed ID: 26496556
[TBL] [Abstract][Full Text] [Related]
3. Combining Diffusion Tensor Metrics and DSC Perfusion Imaging: Can It Improve the Diagnostic Accuracy in Differentiating Tumefactive Demyelination from High-Grade Glioma?
Hiremath SB; Muraleedharan A; Kumar S; Nagesh C; Kesavadas C; Abraham M; Kapilamoorthy TR; Thomas B
AJNR Am J Neuroradiol; 2017 Apr; 38(4):685-690. PubMed ID: 28209583
[TBL] [Abstract][Full Text] [Related]
4. Diffusion-tensor imaging for glioma grading at 3-T magnetic resonance imaging: analysis of fractional anisotropy and mean diffusivity.
Lee HY; Na DG; Song IC; Lee DH; Seo HS; Kim JH; Chang KH
J Comput Assist Tomogr; 2008; 32(2):298-303. PubMed ID: 18379322
[TBL] [Abstract][Full Text] [Related]
5. Proton MR spectroscopy of tumefactive demyelinating lesions.
Saindane AM; Cha S; Law M; Xue X; Knopp EA; Zagzag D
AJNR Am J Neuroradiol; 2002 Sep; 23(8):1378-86. PubMed ID: 12223381
[TBL] [Abstract][Full Text] [Related]
6. Proton magnetic resonance spectroscopy differentiates tumefactive demyelinating lesions from gliomas.
Ikeguchi R; Shimizu Y; Abe K; Shimizu S; Maruyama T; Nitta M; Abe K; Kawamata T; Kitagawa K
Mult Scler Relat Disord; 2018 Nov; 26():77-84. PubMed ID: 30237108
[TBL] [Abstract][Full Text] [Related]
7. Application of diffusion tensor imaging in brain lesions: A comparative study of neoplastic and non-neoplastic brain lesions.
Soni N; Srindharan K; Kumar S; Bhaisora KS; Kalita J; Mehrotra A; Mishra P
Neurol India; 2018; 66(6):1667-1671. PubMed ID: 30504560
[TBL] [Abstract][Full Text] [Related]
8. Can permeability measurements add to blood volume measurements in differentiating tumefactive demyelinating lesions from high grade gliomas using perfusion CT?
Jain R; Ellika S; Lehman NL; Scarpace L; Schultz LR; Rock JP; Rosenblum M; Mikkelsen T
J Neurooncol; 2010 May; 97(3):383-8. PubMed ID: 19830525
[TBL] [Abstract][Full Text] [Related]
9. Differentiating Nonenhancing Grade II Gliomas from Grade III Gliomas Using Diffusion Tensor Imaging and Dynamic Susceptibility Contrast MRI.
Alkanhal H; Das K; Rathi N; Syed K; Poptani H
World Neurosurg; 2021 Feb; 146():e555-e564. PubMed ID: 33152494
[TBL] [Abstract][Full Text] [Related]
10. Diffusion tensor imaging provides an insight into the microstructure of meningiomas, high-grade gliomas, and peritumoral edema.
De Belder FE; Oot AR; Van Hecke W; Venstermans C; Menovsky T; Van Marck V; Van Goethem J; Van den Hauwe L; Vandekerckhove M; Parizel PM
J Comput Assist Tomogr; 2012; 36(5):577-82. PubMed ID: 22992609
[TBL] [Abstract][Full Text] [Related]
11. [Application of diffusion tensor imaging in preoperation and postoperation patients of glioma with 3.0 Tesla MRI].
Li X; Yu RT; Xu K; Li FC; Fan YC; Gao WC; Guo KQ; Pan X; Yang C
Zhonghua Yi Xue Za Zhi; 2009 May; 89(19):1300-4. PubMed ID: 19615179
[TBL] [Abstract][Full Text] [Related]
12. Contribution of diffusion tensor imaging to delineation of gliomas and glioblastomas.
Tropine A; Vucurevic G; Delani P; Boor S; Hopf N; Bohl J; Stoeter P
J Magn Reson Imaging; 2004 Dec; 20(6):905-12. PubMed ID: 15558549
[TBL] [Abstract][Full Text] [Related]
13. Histogram analysis of apparent diffusion coefficient maps for differentiating primary CNS lymphomas from tumefactive demyelinating lesions.
Lu SS; Kim SJ; Kim N; Kim HS; Choi CG; Lim YM
AJR Am J Roentgenol; 2015 Apr; 204(4):827-34. PubMed ID: 25794073
[TBL] [Abstract][Full Text] [Related]
14. Differentiation of residual/recurrent gliomas from postradiation necrosis with arterial spin labeling and diffusion tensor magnetic resonance imaging-derived metrics.
Razek AAKA; El-Serougy L; Abdelsalam M; Gaballa G; Talaat M
Neuroradiology; 2018 Feb; 60(2):169-177. PubMed ID: 29218370
[TBL] [Abstract][Full Text] [Related]
15. Quantitative apparent diffusion coefficients in the characterization of brain tumors and associated peritumoral edema.
Server A; Kulle B; Maehlen J; Josefsen R; Schellhorn T; Kumar T; Langberg CW; Nakstad PH
Acta Radiol; 2009 Jul; 50(6):682-9. PubMed ID: 19449234
[TBL] [Abstract][Full Text] [Related]
16. Peritumoral brain regions in gliomas and meningiomas: investigation with isotropic diffusion-weighted MR imaging and diffusion-tensor MR imaging.
Provenzale JM; McGraw P; Mhatre P; Guo AC; Delong D
Radiology; 2004 Aug; 232(2):451-60. PubMed ID: 15215555
[TBL] [Abstract][Full Text] [Related]
17. Gliomas: diffusion kurtosis MR imaging in grading.
Van Cauter S; Veraart J; Sijbers J; Peeters RR; Himmelreich U; De Keyzer F; Van Gool SW; Van Calenbergh F; De Vleeschouwer S; Van Hecke W; Sunaert S
Radiology; 2012 May; 263(2):492-501. PubMed ID: 22403168
[TBL] [Abstract][Full Text] [Related]
18. Diffusion tensor imaging for preoperative evaluation of tumor grade in gliomas.
Inoue T; Ogasawara K; Beppu T; Ogawa A; Kabasawa H
Clin Neurol Neurosurg; 2005 Apr; 107(3):174-80. PubMed ID: 15823671
[TBL] [Abstract][Full Text] [Related]
19. Distinguishing tumefactive demyelinating lesions from glioma or central nervous system lymphoma: added value of unenhanced CT compared with conventional contrast-enhanced MR imaging.
Kim DS; Na DG; Kim KH; Kim JH; Kim E; Yun BL; Chang KH
Radiology; 2009 May; 251(2):467-75. PubMed ID: 19261924
[TBL] [Abstract][Full Text] [Related]
20. Measurements of diagnostic examination performance using quantitative apparent diffusion coefficient and proton MR spectroscopic imaging in the preoperative evaluation of tumor grade in cerebral gliomas.
Server A; Kulle B; Gadmar ØB; Josefsen R; Kumar T; Nakstad PH
Eur J Radiol; 2011 Nov; 80(2):462-70. PubMed ID: 20708868
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
